Timeline
2022.01
2024
- Registered in Peru, El Salvador, India, Singapore, and Ukraine.
- Published a SCI journal paper on the world’s first mesh scaffold implant (Journal of Cosmetic Dermatology)
- Published a journal paper on the world’s first mesh scaffold implant (Clinical, Cosmetic and Investigational Dermatology)
- Certified as ‘Innovation Business Company’ (INNOBIZ)
2021.01
2023
- Registered in Argentina, Australia, Indonesia, Russia, Malaysia, and Kuwait.
- Certified as ‘Best Family Friendly Management’ (Ministry of Gender Equality and Family)
- Selected as ‘Global IP Star Company’ (Korea Invention Promotion Association)
- Obtained Brazilian-GMP (BGMP) certification for medical devices Class IV
- Obtained Australia’s TGA certification on TESSLIFT SOFT
- Obtained Argentina’s ANMAT certification on TESSLIFT SOFT
- Obtained Indonesia’s BPOM certification on TESSLIFT SOFT
- Obtained Russia’s GOST certification on TESSLIFT SOFT
- Obtained Malaysia’s MDA certification on TESSLIFT SOFT
- Obtained Kuwait’s MOH certification on TESSLIFT SOFT
2020.01
2021-2022
- Obtained CE certification on TESSLIFT SOFT
- TESS Research Institute Established
- Certified as ‘Venture Company’ (Korea Technology Finance Corporation)
- Obtained UAE’s MOHAP certification on TESSLIFT SOFT
- Obtained Saudi Arabia’s FDA(SFDA) certification on TESSLIFT SOFT
- Obtained Guatemala’s DRCPFA certification on TESSLIFT SOFT
- Obtained Israel’s AMAR certification on TESSLIFT SOFT
2019.01
2020
- Obtained Thailand, Ecuador, Vietnam’s TFDA certification on TESSLIFT SOFT
2018.01
2018-2019
- Entered clinical trial on TESSLIFT SOFT with Yonsei University Hospital (Severance Hospital)
- Obtained CE certification on TESSLIFT-160, 020
2017.01
2017
- Obtained ISO 13485 GMP certification (TUV SUD, Germany) for Wonju plant.
- Obtained Ministry of Food and Drug Safety (MFDS) certification on TESSLIFT SOFT
- Patent registered on “Device for Tissue Suspension and Fixation“
- Partnership Agreement with Samsung Seoul Hospital for Government R&D project
2015.01
2015-2016
- stablished Business Center & Training Center in Seoul, Gangnam
- Established the Corporate R&D Center for implant for tissue suspension.
- Corporate R&D Center Accreditation by Korea Industrial Technology Association (KOITA)
2014.01
2014
- Obtained Korean-GMP (KGMP) certification for medical devices Class IV & Class III
- Obtained Ministry of Food and Drug Safety (MFDS) certification on TESSLIFT-010
2013.01
2013
- International trademark registrations for Madrid (Associated countries: Australia, China, EU, Japan, Russia, USA
- Established the first plant and head office at Wonju Medical Industry Techno Valley
- Registered for manufacturing business for medical devices.
2012.01
2012
- Patent PCT International Application for “Graft for Tissue Lifting” 9PCT/KR2012/004421
2008.01
2008
- Established the TESS Co., Ltd.
- Collaborations among biomedical engineers and surgeons have established R&D of an implant for tissue suspension.
